These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: prospective comparison with single-photon emission computed tomography. Abdelmoneim SS, Basu A, Bernier M, Dhoble A, Abdel-Kader SS, Pellikka PA, Mulvagh SL. Diab Vasc Dis Res; 2011 Oct; 8(4):254-61. PubMed ID: 21933841 [Abstract] [Full Text] [Related]
3. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. Di Carli MF, Janisse J, Grunberger G, Ager J. J Am Coll Cardiol; 2003 Apr 16; 41(8):1387-93. PubMed ID: 12706936 [Abstract] [Full Text] [Related]
6. Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes. Schindler TH, Facta AD, Prior JO, Cadenas J, Hsueh WA, Quinones MJ, Schelbert HR. Heart; 2007 Mar 16; 93(3):345-9. PubMed ID: 16940388 [Abstract] [Full Text] [Related]
8. Diabetes mellitus and coronary microvascular function in asymptomatic patients with severe aortic stenosis and nonobstructed coronary arteries. Banovic M, Brkovic V, Nedeljkovic I, Nedeljkovic M, Popovic D, Djordjevic-Dikic A, Ristic A, Nikolic S, Beleslin B. Diab Vasc Dis Res; 2016 May 16; 13(3):220-7. PubMed ID: 26993497 [Abstract] [Full Text] [Related]
9. Decreased endothelium-dependent coronary vasomotion in healthy young smokers. Iwado Y, Yoshinaga K, Furuyama H, Ito Y, Noriyasu K, Katoh C, Kuge Y, Tsukamoto E, Tamaki N. Eur J Nucl Med Mol Imaging; 2002 Aug 16; 29(8):984-90. PubMed ID: 12173010 [Abstract] [Full Text] [Related]
12. [Dysfunction of the coronary microcirculation in type 2 diabetic patients]. Nitenberg A, Ledoux S, Valensi P, Sachs R, Attali JR, Antony I. Arch Mal Coeur Vaiss; 2000 Aug 16; 93(8):937-41. PubMed ID: 10989733 [Abstract] [Full Text] [Related]
13. Coronary vascular dysfunction in premenopausal women with diabetes mellitus. Di Carli MF, Afonso L, Campisi R, Ramappa P, Bianco-Batlles D, Grunberger G, Schelbert HR. Am Heart J; 2002 Oct 16; 144(4):711-8. PubMed ID: 12360169 [Abstract] [Full Text] [Related]
14. Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus--a randomized study using positron emission tomography. Bengel FM, Abletshauser C, Neverve J, Schnell O, Nekolla SG, Standl E, Schwaiger M. Diabet Med; 2005 Feb 16; 22(2):158-63. PubMed ID: 15660732 [Abstract] [Full Text] [Related]
15. Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease. Yokoyama I, Yonekura K, Ohtake T, Yang W, Shin WS, Yamada N, Ohtomo K, Nagai R. J Nucl Med; 2000 Jun 16; 41(6):978-85. PubMed ID: 10855621 [Abstract] [Full Text] [Related]
19. Coronary microvascular adaptation to myocardial metabolic demand can be restored by inhibition of iron-catalyzed formation of oxygen free radicals in type 2 diabetic patients. Nitenberg A, Ledoux S, Valensi P, Sachs R, Antony I. Diabetes; 2002 Mar 16; 51(3):813-8. PubMed ID: 11872685 [Abstract] [Full Text] [Related]
20. Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus. Schindler TH, Facta AD, Prior JO, Cadenas J, Zhang XL, Li Y, Sayre J, Goldin J, Schelbert HR. Eur J Nucl Med Mol Imaging; 2009 Feb 16; 36(2):219-29. PubMed ID: 18704406 [Abstract] [Full Text] [Related] Page: [Next] [New Search]